25.3 C
New York
Saturday, June 13, 2026

Tag: challenge

newssourceFORcompanyinformationcontent1marketreleases

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

The American Diabetes Association Announces Winners of the Innovation Challenge

NEW ORLEANS, June 6, 2026 /PRNewswire/ -- Today, from the main stage at the organization's 2026 Scientific Sessions, the American Diabetes Association® (ADA) announced...

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may...

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing...

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...

Denovia Advances “The Ark” From Launch to Commercial Scale-Up, Targeting the Trillion-Dollar Plastic and Textile Waste Opportunity

Six months after launching The Ark, Denovia is advancing financing activities, strategic partnerships, and commercial deployment plans to scale its breakthrough recycling platform into...

Denovia Advances “The Ark” From Launch to Commercial Scale-Up, Targeting the Trillion-Dollar Plastic and Textile Waste Opportunity

Six months after launching The Ark, Denovia is advancing financing activities, strategic partnerships, and commercial deployment plans to scale its breakthrough recycling platform into...

How Can Beginners Use AI Stock Trading Bots? BulkQuant Launches a Stock Quant Trading Tool With Simple Setup

BulkQuant introduces a simplified stock quant trading tool designed to help beginners explore AI stock trading bots without coding, complex setup, or advanced strategy configuration. 
BulkQuant introduces a simplified stock quant trading tool designed to help beginners explore AI stock trading bots without coding, complex setup, or advanced strategy configuration.

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...

13th Monaco Energy Boat Challenge 8-11 July 2026 Monaco as a global laboratory for sustainable yachting

With a record 56 teams signed up, innovation, energy and the future of navigation are set to converge on the 2026 Monaco Energy Boat Challenge 
With a record 56 teams signed up, innovation, energy and the future of navigation are set to converge on the 2026 Monaco Energy Boat Challenge

GENESIS MAGMA RACING PREPARES FOR FIRST 24 HOURS OF LE MANS

Genesis Magma Racing expects a tough challenge as it takes on the 24 Hours of Le Mans, the centerpiece of the FIA World Endurance...

UREVO Debuts Smart Wellness Pop-Up in SoHo

UREVO Debuts Smart Wellness Pop-Up in SoHo--Three-day public experience during New York Tech Week showcases the future of active work and recovery

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsChallenge

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers